Movement toward optimization of CLL therapy
- PMID: 24645950
- DOI: 10.1056/NEJMe1400599
Movement toward optimization of CLL therapy
Comment on
-
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions.N Engl J Med. 2014 Mar 20;370(12):1101-10. doi: 10.1056/NEJMoa1313984. Epub 2014 Jan 8. N Engl J Med. 2014. PMID: 24401022 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources